Skip to Content


In the US, Riluzole (riluzole systemic) is a member of the drug class miscellaneous uncategorized agents and is used to treat Amyotrophic Lateral Sclerosis and Obsessive Compulsive Disorder.

US matches:

UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Glutamate antagonist

Neuroprotective agent

Chemical Name

2-Benzotiazolamine, 6-(trifluorometoxy)-

Foreign Names

  • Riluzolum (Latin)
  • Riluzol (German)
  • Riluzole (French)
  • Riluzol (Spanish)

Generic Names

  • Riluzole (OS: BAN, DCF, USAN, JAN)
  • PK 26124 (IS)
  • RP 54274 (IS: RhônePoulencR)
  • Riluzole (PH: USP 37)

Brand Names

  • Apo-Riluzole
    Apotex, Australia
  • Borizol
    SIC BHFZ, Georgia
  • Extensik
    Sandoz, Colombia
  • Fanizan
    Actavis, Estonia
  • Glentek
    Glenmark, Denmark
  • Laidec
    Sun Pro, Taiwan
  • Lizolorol
    ratiopharm, Estonia
  • Lizorolol
    ratiopharm, Netherlands
  • Rilasat
    Buxton, Argentina
  • Rilustad
    STADA, Estonia
  • Rilutek
    Aventis, Hungary; Aventis, Iceland; Aventis, Slovenia; Aventis Intercontinental, Lebanon; Aventis Pharma, Greece; Aventis Pharma, Norway; Sanofi, Sweden; Sanofi Aventis, Brazil; Sanofi Aventis, China; Sanofi Aventis, Spain; Sanofi Aventis, Japan; Sanofi Winthrop, Georgia; Sanofi Winthrop, Serbia; Sanofi-Aventis, Argentina; Sanofi-Aventis, Austria; Sanofi-Aventis, Australia; Sanofi-Aventis, Belgium; Sanofi-Aventis, Switzerland; Sanofi-Aventis, Chile; Sanofi-Aventis, Colombia; Sanofi-Aventis, Germany; Sanofi-Aventis, Denmark; Sanofi-Aventis, Egypt; Sanofi-Aventis, France; Sanofi-Aventis, United Kingdom; Sanofi-Aventis, Hong Kong; Sanofi-Aventis, Ireland; Sanofi-Aventis, Italy; Sanofi-Aventis, Lithuania; Sanofi-Aventis, Latvia; Sanofi-Aventis, Mexico; Sanofi-Aventis, Netherlands; Sanofi-Aventis, New Zealand; Sanofi-Aventis, Peru; Sanofi-Aventis, Portugal; Sanofi-Aventis, Romania; Sanofi-Aventis, Singapore; Sanofi-Aventis, Thailand; Sanofi-Aventis, Turkey; Sanofi-Aventis, Taiwan
  • Riluzol - 1 A Pharma
    1 A Pharma, Germany
  • Riluzol 1A Pharma
    1A Pharma, Netherlands
  • Riluzol Actavis
    Actavis, Denmark; Actavis, Netherlands; Actavis, Portugal; Actavis, Sweden; Actavis Group, Iceland
  • Riluzol CF
    Centrafarm, Netherlands
  • Riluzol Combino
    Combino, Portugal
  • Riluzol easypharm
    Easypharm, Austria
  • Riluzol Generis
    Generis, Portugal
  • Riluzol Hexal
    Hexal, Germany; Hexal, Netherlands
  • Riluzol Mylan
    Mylan, Poland; Mylan dura, Germany; Mylan, Netherlands; Mylan, Portugal
  • Riluzol PMCS
    Evolan, Sweden; Matrix Pharmaceuticals, Denmark; Pro.Med., Poland; Pro.Med.CS, Austria
  • Riluzol Sandoz
    Sandoz, Netherlands
  • Riluzol STADA
    PharmaCoDane, Sweden; STADA, Germany
  • Riluzol Sun
    Sun Pharma, Netherlands
  • Riluzol Teva
    Teva, Netherlands; Teva Pharma, Portugal
  • Riluzol Zentiva
    Sanofi-Aventis, Portugal
  • Riluzol-CT
    AbZ-Pharma, Germany
  • Riluzole Actavis
    Actavis, Estonia; Actavis, United Kingdom; Actavis, Lithuania
  • Riluzole ESP Pharma
    ESP Pharma, Estonia
  • Riluzole Sandoz
    Sandoz, Australia
  • Riluzole STADA
    STADA, Estonia
  • Riluzole Sun
    Sun Pharma, United Kingdom
  • Riluzole Teva
    Teva, Estonia; Teva, Sweden
  • Riluzole Zentiva
    Zentiva, Lithuania
  • Riluzole-Nhwa Pharm
    Nhwa, China
  • Riluzol-Hormosan
    Hormosan Pharma, Germany
  • Riluzol-neuraxpharm
    neuraxpharm, Germany
  • Riluzol-ratiopharm
    ratiopharm, Germany
  • Rimipole
    Actavis, Estonia
  • Rizol
    Aspen, Argentina
  • Sclefic
    Actavis, Estonia; Actavis, Hungary; Actavis, Malta; Actavis, Slovenia; Actavis Group, Poland
  • Xie Yi Li
    Lunan Pharm, China
  • Zolerilis
    Actavis, Estonia; Adamed, Poland

International Drug Name Search


BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.